drugset / Trial / NCT03950960

A Study to Investigate the Effects of Itraconazole on the Pharmacokinetics of BMS-986256 in Healthy Participants

NCT03950960

Phase 1 Completed 15 enrolled Bristol-Myers Squibb
SequentialOpen-labelTreatment

Summary

The purpose of this study is to evaluate the effect of cytochrome P450 3A4 inhibition by Itraconazole on the pharmacokinetics of BMS-986256.

Timeline

Start
2019-05-02
Primary completion
2019-07-31
Completion
2019-08-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Afimetoran Small molecule
Subject Itraconazole Small molecule

Indications

No indication recorded.